NCAPD2 and cancer: We identified a total of six hub genes: BIRC5, CDCA2, SMC4, CDC20, NCAPD2, and KIFC1. Among the hub genes, BIRC5 (also named survivin) is a well-known cancer therapeutic target (Li et al., 2019).